This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Glaxosmithkline Biologicals Sa. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Luigi Lay and Vaccine-Related Inventions.
Introduction.
Luigi Lay is an inventor based in Milan, Italy, whose work includes an invention in the field of vaccines. His listed patent is titled “Carbocyclic Derivatives and Conjugated Derivatives Thereof, and Their Use in Vaccines.” Lay is associated with GlaxoSmithKline Biologicals SA.
Latest Patents.
The supplied information lists one patent for Lay: 1 patent. The invention concerns oligomers made by connecting selected numbers of carbocyclic repeating units, along with conjugated derivatives of those oligomers. The compounds have selected degrees of polymerization and acetylation and are described as useful in preparing immunogenic compositions, including vaccines.
Career Highlights.
Lay’s listed patent reflects work on vaccine-related compounds and their potential use in immunogenic compositions. The available information identifies his association with GlaxoSmithKline Biologicals SA but does not provide further details about his role or career history.
Collaborations.
Francesco Berti and Roberto Adamo are identified as Lay’s coworkers. The supplied information does not specify their individual contributions to the patent.
Conclusion.
Luigi Lay’s listed invention focuses on carbocyclic oligomers and their conjugated derivatives as potential components of vaccine preparations, highlighting his connection to vaccine-related innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
